Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 10
1990 20
1991 31
1992 30
1993 59
1994 46
1995 47
1996 32
1997 58
1998 67
1999 88
2000 87
2001 94
2002 92
2003 128
2004 131
2005 155
2006 152
2007 146
2008 140
2009 139
2010 150
2011 145
2012 135
2013 103
2014 86
2015 82
2016 59
2017 63
2018 65
2019 31
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2,366 results
Results by year
Filters applied: . Clear all
Page 1
Postmenopausal osteoporosis and breast cancer: The biochemical links and beneficial effects of functional foods.
Muhammad A, et al. Biomed Pharmacother 2018 - Review. PMID 30114641
Osteoporosis, a condition characterized by altered bone mineralization is also commonly found among post-menopausal women. Consequently, post-menopausal women are at risk of morbidity and mortality associated with breast cancer and postmenopausal osteoporosis. ...As a result, the potentials of antioxidant rich functional foods in preventing, managing and possibly treating breast cancer and postmenopausal osteoporosis cannot be overemphasised. ...
Osteoporosis, a condition characterized by altered bone mineralization is also commonly found among post-menopausal women. Consequent
Factors related with osteoporosis treatment in postmenopausal women.
Rossi LMM, et al. Medicine (Baltimore) 2018 - Clinical Trial. PMID 29995822 Free PMC article.
The aim of this study was to identify factors associated with osteoporosis treatment in postmenopausal women.A cross-sectional study was carried out from March to August 2013 at the primary care setting. ...The factors independently associated with treatment in the regression analysis were the DXA scan itself, the diagnosis of osteoporosis by DXA, and information about osteoporosis.Current and past treatments of osteoporosis were associated with DXA and information. ...
The aim of this study was to identify factors associated with osteoporosis treatment in postmenopausal women.A cross-sectional …
Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Kanis JA, et al. Aging Clin Exp Res 2019. PMID 30612282
A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis was recently published in Osteoporosis International as a joint effort of the International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (Kanis et al. Osteoporos Int, https://doi.org/10.1007/s00198-018-4704-5 , 2018). This manuscript updates the previous guideline document, published in 2013 (Kanis et al. ...
A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis was recently pub …
Association between periodontal changes and osteoporosis in postmenopausal women.
Pereira FM, et al. Climacteric 2015. PMID 25263313
OBJECTIVE: To investigate the possible association between periodontal changes and osteoporosis in postmenopausal women through a longitudinal study. ...CONCLUSIONS: The findings suggest that periodontal changes can be associated with osteoporosis in postmenopausal women....
OBJECTIVE: To investigate the possible association between periodontal changes and osteoporosis in postmenopausal women throug …
Current controversies in clinical management of postmenopausal osteoporosis.
Kerschan-Schindl K, et al. Exp Clin Endocrinol Diabetes 2014 - Review. PMID 24838156
Osteoporosis is a frequent disease in postmenopausal women. Despite the fact that fragility fractures cause many problems - a bio-psycho-social burden for the individual and an economic burden for the society - osteoporosis is still underdiagnosed and undertreated. ...
Osteoporosis is a frequent disease in postmenopausal women. Despite the fact that fragility fractures cause many problems - a
Bisphosphonates for postmenopausal osteoporosis.
Eastell R, et al. Bone 2011 - Review. PMID 21349354
Bisphosphonates are effective in reducing bone turnover, increasing BMD and reducing fracture risk in postmenopausal women with osteoporosis. ...
Bisphosphonates are effective in reducing bone turnover, increasing BMD and reducing fracture risk in postmenopausal women with os
[Postmenopausal osteoporosis in women].
Reginster JY, et al. Rev Med Liege 1999. PMID 10389480 French. Free article.
Postmenopausal osteoporosis is now considered a major public health problem in aging women, due to the burden related to the consequent fractures. ...Hormone replacement therapy is the first choice in prevention of postmenopausal osteoporosis. Based on a careful evaluation of the needs of a postmenopausal woman as well as on the risk/benefit ratio derived from her individual risk factors, selective estrogen receptor modulators (raloxifene) or second generation bisphosphonates (alendronate) can be considered as alternative to estrogens. ...
Postmenopausal osteoporosis is now considered a major public health problem in aging women, due to the burden related to the c
Osteoporosis.
Brown SA and Rosen CJ. Med Clin North Am 2003 - Review. PMID 14621330
Osteoporosis is a disease that may have a tremendous impact on the lives of many postmenopausal women. It is encouraging that effective treatments for this disease abound and the challenge is to ensure that those most in need of diagnosis or therapy obtain adequate care. ...There is an array of efficacious options to consider when diagnosing and treating osteoporosis so that patients and their caregivers can remain optimistic about the management of this chronic disease and prevention of future fractures....
Osteoporosis is a disease that may have a tremendous impact on the lives of many postmenopausal women. It is encouraging that
Bone Density and Clinical Periodontal Attachment in Postmenopausal Women: A Systematic Review and Meta-Analysis.
Penoni DC, et al. J Dent Res 2017 - Review. PMID 28048966
Eligibility criteria included studies that compared clinical attachment loss (CAL) between postmenopausal women with low and normal BMD. ...This systematic review and meta-analysis indicates that postmenopausal women with osteoporosis or osteopenia may exhibit greater CAL compared with women with normal BMD....
Eligibility criteria included studies that compared clinical attachment loss (CAL) between postmenopausal women with low and normal B …
Bone Health and Osteoporosis.
Lupsa BC and Insogna K. Endocrinol Metab Clin North Am 2015 - Review. PMID 26316240
Osteoporosis is characterized by low bone mass and microarchitectural deterioration of bone tissue leading to decreased bone strength and an increased risk of low-energy fractures. ...Bone loss is an inevitable consequence of the decrease in estrogen levels during and following menopause, but additional risk factors for bone loss can also contribute to osteoporosis in older women. ...
Osteoporosis is characterized by low bone mass and microarchitectural deterioration of bone tissue leading to decreased bone strength
2,366 results
Jump to page
Feedback